Nutex Health extends stock repurchase program

Nutex Health (NUTX) announced that its board of directors has approved an extension of the previously authorized stock repurchase program. The program, originally announced on August 14, authorized the repurchase of up to $25M of the company’s common stock over a six-month period, commencing upon the filing of the company’s Form 10-Q for the quarter ended June 30. The board has extended the program through March 31, 2026. The repurchase plan will be implemented in accordance with the provisions of Rule 10b-18 under the Securities Exchange Act of 1934, as amended, and under a Rule 10b5-1 trading plan, which is scheduled to go into effect on or about December 4.